JPRN-UMIN000041086已完成未知
Immune checkpoint inhibitors versus ramucirumab plus docetaxel for refractory or relapsed advanced non-small cell lung cancer: A systematic review and network meta-analysis of phase 3 randomized clinical trials. - Immune checkpoint inhibitors versus ramucirumab plusdocetaxel for refractory or relapsed advanced NSCLC
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 1,526
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Others,meta-analysis etc
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(The article search were restricted to those published in the English language)
研究者
相似试验
已完成
不适用
Immune checkpoint inhibitor versus chemotherapy for elderly non-small cell lung cancer:a meta-analysisnon-small cell lung cancerJPRN-UMIN000036706Department of Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine1,920
已完成
不适用
Efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer other than adenocarcinoma or squamous cell carcinoma: multicenter retrospective observational studyon-small cell lung cancer other than adenocarcinoma or squamous cell carcinomaJPRN-UMIN000037777Hamamatsu University School of Medicine60
已完成
不适用
The usefulness of immune checkpoint inhibitors among lung cancer patients with driver gene mutantsung cancerJPRN-UMIN000040789Yokohama City University
招募中
不适用
Immune checkpoint inhibitors and drug-induced colitispatients who are going to administered immune checkpoint inhibitorJPRN-UMIN000032854Shiga University of Medical Science50
进行中（未招募）
1 期
Pre-operative immunotherapy in early-stage colon cancersEUCTR2016-002940-17-NLAntoni van Leeuwenhoek155